Search

Your search keyword '"Dan, Yock‐Young"' showing total 591 results

Search Constraints

Start Over You searched for: Author "Dan, Yock‐Young" Remove constraint Author: "Dan, Yock‐Young"
591 results on '"Dan, Yock‐Young"'

Search Results

1. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024

3. 919 GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES

4. Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH

5. Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver

6. Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma

8. A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and ‘bad apple’ effect on clinical trajectory

9. Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease

10. Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon

11. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis

12. Rising global burden of cancer attributable to high BMI from 2010 to 2019

14. Platform for the interdisciplinary study of cardiovascular, metabolic and neurovascular diseases (PICMAN) protocol

16. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals

17. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies

19. Contributors

20. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

21. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis

24. Pan-cancer pervasive upregulation of 3′ UTR splicing drives tumourigenesis

29. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study

31. Trajectory of immune evasion and cancer progression in hepatocellular carcinoma

33. THU-200-YI Clearance of senescent cells alleviates metabolic dysfunction-associated steatohepatitis

34. SAT-281 Clinical characteristics, surveillance, treatment allocation and outcomes of alcohol-related hepatocellular carcinoma: meta-analysis of 37 studies and 66, 559 patients

35. WED-238 High pancreatic fat and reduced volume stratify patients with F4 liver fibrosis

36. Single-cell and spatial atlas of steatotic liver-related hepatocellular carcinoma

38. Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer

41. The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis

42. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality

45. SARS-CoV-2 in migrant worker dormitories: Geospatial epidemiology supporting outbreak management

49. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

50. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma

Catalog

Books, media, physical & digital resources